Literature DB >> 3387893

Increased plasma levels of peptide YY in coeliac disease.

K Sjölund1, R Ekman.   

Abstract

Peptide YY (PYY) is exclusively localized in endocrine cells in the gut, and these cells are most numerous in the distal small intestine, colon, and rectum. We have earlier shown that PYY coexists with enteroglucagon in the gut endocrine cells. High basal and postprandial plasma enteroglucagon concentrations have earlier been found in patients with untreated coeliac disease. PYY circulates in human plasma and is detectable in most healthy adults. We have therefore studied the basal PYY levels in patients with coeliac disease. Marked elevated basal plasma PYY levels were found in patients with coeliac disease compared with an age- and sex-matched control group. The PYY levels were inversely correlated to the concentration of folate acid in serum. The PYY levels were studied in four patients with newly diagnosed disease and had normalized within 8 months on a gluten-free diet.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3387893     DOI: 10.3109/00365528809093868

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  Basal and fat-stimulated plasma peptide YY levels in celiac disease.

Authors:  P J Wahab; W P Hopman; J B Jansen
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

2.  Jejunal overexpression of peptide YY in celiac disease complicated with pneumatosis cystoides intestinalis.

Authors:  Angela Gurrado; Simone Giungato; Ivana Catacchio; Domenico Piscitelli; Graziana Arborea; Giuseppe Piccinni; Mario Testini; Angelo Vacca
Journal:  Clin Exp Med       Date:  2014-10-08       Impact factor: 3.984

3.  Gut hormones and gastrointestinal motility in children with cystic fibrosis.

Authors:  M S Murphy; A L Brunetto; A D Pearson; M A Ghatei; R Nelson; E J Eastham; S R Bloom; A A Green
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

Review 4.  The role of peptide YY in gastrointestinal diseases and disorders (review).

Authors:  Magdy El-Salhy; Tarek Mazzawi; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  Int J Mol Med       Date:  2012-12-21       Impact factor: 4.101

5.  Increased fasting small-bowel water content in untreated coeliac disease and scleroderma as assessed by magnetic resonance imaging.

Authors:  Ching Lam; David S Sanders; Peter Lanyon; Klara Garsed; Stephen Foley; Susan Pritchard; Luca Marciani; Caroline L Hoad; Carolyn Costigan; Penny Gowland; Robin Spiller
Journal:  United European Gastroenterol J       Date:  2019-06-21       Impact factor: 4.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.